Vermillion Return on Investment 2006-2019 | VRML

Current and historical return on investment (ROI) values for Vermillion (VRML) over the last 10 years.
Vermillion ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2019-09-30 $-0.02B $0.01B -146.34%
2019-06-30 $-0.01B $0.02B -143.59%
2019-03-31 $-0.01B $0.01B -140.54%
2018-12-31 $-0.01B $0.01B -137.14%
2018-09-30 $-0.01B $0.01B -150.00%
2018-06-30 $-0.01B $0.01B -157.14%
2018-03-31 $-0.01B $0.00B -190.48%
2017-12-31 $-0.01B $0.01B -153.85%
2017-09-30 $-0.01B $0.01B -153.85%
2017-06-30 $-0.01B $0.01B -162.96%
2017-03-31 $-0.01B $0.01B -162.50%
2016-12-31 $-0.02B $0.01B -162.16%
2016-09-30 $-0.02B $0.01B -212.50%
2016-06-30 $-0.02B $0.01B -165.22%
2016-03-31 $-0.02B $0.01B -228.57%
2015-12-31 $-0.02B -345.45%
2015-09-30 $-0.02B $0.02B -327.27%
2015-06-30 $-0.02B inf%
2015-03-31 $-0.02B inf%
2014-12-31 $-0.02B inf%
2014-09-30 $-0.02B inf%
2014-06-30 $-0.01B inf%
2014-03-31 $-0.01B inf%
2013-12-31 $-0.01B inf%
2013-09-30 $-0.01B inf%
2013-06-30 $-0.01B inf%
2013-03-31 $-0.01B inf%
2012-12-31 $-0.01B inf%
2012-09-30 $-0.01B inf%
2012-06-30 $-0.01B -280.00%
2012-03-31 $-0.02B -145.45%
2011-12-31 $-0.02B -98.63%
2011-09-30 $-0.02B $0.02B -89.41%
2011-06-30 $-0.02B $0.02B -94.74%
2011-03-31 $-0.02B $0.03B -123.08%
2010-12-31 $-0.02B $0.01B -260.87%
2008-12-31 $-0.02B -352.94%
2008-09-30 $-0.02B $0.00B -200.00%
2008-06-30 $-0.02B $0.01B -146.94%
2008-03-31 $-0.02B $0.01B -171.43%
2007-12-31 $-0.02B $0.02B -176.00%
2007-09-30 $-0.02B $0.02B -188.24%
2007-06-30 $-0.03B $0.01B -178.57%
2007-03-31 $-0.03B $0.01B -133.33%
2006-12-31 $-0.03B $0.02B -99.01%
2006-09-30 $-0.03B $0.02B -84.55%
2006-06-30 $-0.03B $0.03B -74.48%
2006-03-31 $-0.03B $0.03B -72.73%
2005-12-31 $-0.03B $0.04B -77.11%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.081B $0.003B
Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. Vermillion also intends to address clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others. Its lead product includes the OVA1 ovarian tumor triage test, which addresses presurgical identification of women who are at high risk of having a malignant ovarian tumor. In addition to the OVA1 Test, Vermillion has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease. Vermillion, Inc. is based in Fremont, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $136.233B 27.53
Intuitive Surgical (ISRG) United States $71.316B 53.24
Edwards Lifesciences (EW) United States $49.209B 42.25
DexCom (DXCM) United States $26.716B 159.39
Olympus (OCPNY) Japan $25.403B 190.77
IDEXX Laboratories (IDXX) United States $24.828B 59.63
Fresenius Medical Care AG KGaA (FMS) Germany $24.771B 16.76
Teleflex (TFX) United States $18.293B 37.14
SONOVA HOLDING (SONVY) Switzerland $16.773B 0.00
STERIS (STE) Ireland $14.271B 30.43
Sysmex ADR (SSMXY) Japan $13.992B 37.66
Hologic (HOLX) United States $13.944B 21.44
Varian Medical Systems (VAR) United States $13.292B 30.93
Masimo (MASI) United States $9.720B 56.59
SARTORIUS AG (SARTF) Germany $7.971B 70.82
ABIOMED (ABMD) United States $7.566B 39.88
Penumbra (PEN) United States $6.765B 220.18
Globus Medical (GMED) United States $5.623B 34.70
Tandem Diabetes Care (TNDM) United States $5.321B 0.00
Integra LifeSciences Holdings (IART) United States $5.241B 22.28
Elekta AB (EKTAY) Sweden $4.533B 38.27
Nevro (NVRO) United States $4.475B 0.00
Wright Medical Group (WMGI) Netherlands $3.864B 234.23
LivaNova (LIVN) United Kingdom $3.388B 24.39
Integer Holdings (ITGR) United States $3.047B 20.86
Cantel Medical (CMD) United States $2.951B 28.88
Nihon Kohden (NHNKY) Japan $2.784B 28.02
Glaukos (GKOS) United States $2.452B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.491B 29.35
Silk Road Medical (SILK) United States $1.446B 0.00
Veracyte (VCYT) United States $1.306B 0.00
Tactile Systems Technology (TCMD) United States $1.219B 139.26
ShockWave Medical (SWAV) United States $1.211B 0.00
Mesa Laboratories (MLAB) United States $1.170B 61.26
Luminex (LMNX) United States $1.074B 0.00
OPKO Health (OPK) United States $1.065B 0.00
Natus Medical (NTUS) United States $1.051B 24.66
Inogen (INGN) United States $1.000B 31.57
CryoLife (CRY) United States $0.984B 84.64
Intersect ENT (XENT) United States $0.900B 0.00
Accelerate Diagnostics (AXDX) United States $0.895B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.877B 29.13
OrthoPediatrics (KIDS) United States $0.820B 0.00
Pacific Biosciences Of California (PACB) United States $0.687B 0.00
Quotient (QTNT) Switzerland $0.585B 0.00
AxoGen (AXGN) United States $0.583B 0.00
Si-Bone (SIBN) United States $0.522B 0.00
AngioDynamics (ANGO) United States $0.478B 21.90
Alphatec Holdings (ATEC) United States $0.417B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.396B 11.98
RTI Surgical (RTIX) United States $0.351B 95.00
Semler Scientific (SMLR) United States $0.343B 47.73
ViewRay (VRAY) United States $0.324B 0.00
SeaSpine Holdings (SPNE) United States $0.313B 0.00
Accuray (ARAY) United States $0.309B 0.00
IRadimed (IRMD) United States $0.303B 35.70
Stereotaxis (STXS) United States $0.300B 0.00
CRH Medical (CRHM) Canada $0.294B 82.00
Sientra (SIEN) United States $0.291B 0.00
Fluidigm (FLDM) United States $0.263B 0.00
Restoration Robotics (VERO) Canada $0.236B 0.00
GenMark Diagnostics (GNMK) United States $0.232B 0.00
Spectral Diagnostics (EDTXF) Canada $0.127B 0.00
EDAP TMS S.A (EDAP) France $0.115B 30.46
Electromed (ELMD) United States $0.102B 28.00
Second Sight Medical Products (EYES) United States $0.088B 0.00
Sensus Healthcare (SRTS) United States $0.073B 0.00
ConforMIS (CFMS) United States $0.066B 0.00
Neuronetics (STIM) United States $0.062B 0.00
Apollo Endosurgery (APEN) United States $0.061B 0.00
T2 Biosystems (TTOO) United States $0.048B 0.00
Bioanalytical Systems (BASI) United States $0.047B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.035B 0.00
TransEnterix (TRXC) United States $0.032B 0.00
Ekso Bionics Holdings (EKSO) United States $0.032B 0.00
Helius Medical Technologies (HSDT) United States $0.028B 0.00
Neovasc (NVCN) Canada $0.028B 0.00
Ra Medical Systems (RMED) United States $0.024B 0.00
DarioHealth (DRIO) Israel $0.020B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.019B 0.00
Xtant Medical Holdings (XTNT) United States $0.016B 0.00
OBALON THERPTCS (OBLN) United States $0.014B 0.00
American Shared Hospital Services (AMS) United States $0.014B 20.32
Lianluo Smart (LLIT) China $0.014B 0.00
Nanovibronix (NAOV) United States $0.012B 0.00
Avinger (AVGR) United States $0.011B 0.00
ENDRA Life Sciences (NDRA) United States $0.011B 0.00
Dynatronics (DYNT) United States $0.009B 0.00
Micron Solutions (MICR) United States $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
ReWalk Robotics (RWLK) Israel $0.006B 0.00
InspireMD (NSPR) Israel $0.004B 0.00
Viveve Medical (VIVE) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Sunshine Heart Inc (CHFS) United States $0.002B 0.00